IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MPM Asset Management LLC

Q2 2014 Holdings

Filed 2014-07-17 | 14 holdings | $297.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Radius Health, Inc.Common750469207$75.8K5,831,25325.5%
EpiZyme, Inc.(EPZMEUR)Common29428V104$75.1K2,413,81925.3%
Portola Pharmaceuticals, Inc.Common737010108$35.6K1,220,67212.0%
Aratana Therapeutics Inc.(PETXEUR)Common03874P101$32.7K2,093,84511.0%
Trivascular Technologies, Inc.Common89685A102$27.7K1,776,6929.3%
Celladon CorporationCommon15117E107$17.1K1,066,7745.7%
Conatus Pharmaceuticals, Inc.(CNATEUR)Common20600T108$10.9K1,192,0803.7%
PharmAthene, Inc.Common71714G102$9.0K6,347,6143.0%
Verastem, Inc.Common92337C104$7.4K816,6832.5%
Pacira Pharmaceuticals, Inc.(PCRX)Common695127100$3.6K39,0251.2%
EnteroMedics, Inc.Common29365M208$1.7K1,113,1680.6%
Sangamo Biosciences, Inc.(SGMO)Common800677106$34322,4870.1%
Mast Therapeutics, Inc.Common576314108$331524,8530.1%
MacroGenics, Inc.(MGNX)Common556099109$693,1680.0%